Biopharmaceutical executive and non-executive director, providing leadership in therapeutics and associated technology business development and licensing, strategic alliance management, start-up activities, new product planning and development, corporate strategy development, fund raising, financial valuations and business forecasting. Current Head of Business Development and Strategic Alliances at iQone Healthcare Switzerland. Former Chief Business Officer at Ovoca Bio plc and Head of Business Development and Licensing at La Jolla Pharmaceutical Company (NASDAQ)Previously, fifteen years of international pharmaceutical and biotech experience at Pfizer and Eli Lilly, leading on to advisory services to start up and development stage companies and co-founding a spin-out company from UCSD/Scripps Research Institute.Extensive pharmaceutical product commercialization experience, including as global commercial leader on Pfizer’s ChantixTM and SelzentryTM product development teams and in sales management for the launch of Lilly’s ZyprexaTM in the UK. Leadership positions on Pfizer product licensing teams and on infectious disease and ophthalmic task forces defining therapeutic area strategy.